Post-authorization safety (PAS) studies play a crucial role in ensuring the ongoing safety and effectiveness profile of pharmaceuticals after regulatory approval.The PAS studies monitor products…
Klaus Elfving23/11/2023
We are delighted to share that Pezhman Baran has joined our Medical Data Science team in Helsinki.Pezhman is a friendly and sociable person who likes…
Klaus Elfving19/09/2023
Several MedEngine teams gain senior level expertise, as industry veteran Sami Nikoskelainen joins the company. Sami will add proficiency to all current and new projects…
Klaus Elfving15/08/2023
During past year, the MedEngine team has grown remarkably. With the expansion to Nordics, we’ve had the pleasure to welcome a number of new co-workers…
Klaus Elfving14/04/2022
With the acquisition of ApHER, the Institute of Applied Economics & Health Research, we’re happy to welcome a number of new co-workers. This time in…
Klaus Elfving16/11/2021
With the acquisition of ApHER, the Institute of Applied Economics & Health Research, we’re happy to welcome a number of new co-workers. Today in our…
Klaus Elfving01/07/2021
MedEngine has been granted a partnership in the European Network of Centres for Pharmacoepidemiology & Pharmacovigilance (ENCePP), an initiative that brings together expertise and resources…
Miika Fadjukov27/10/2020
Welcome to watch the bonus episode of Insight Talks! It has been an exceptional spring this year, and we can't wait to get back to…
Miika Fadjukov25/06/2020
THL Biobank, a nationwide biobank hosted by the Finnish Institute for Health and Welfare, and MedEngine Oy, a company specialized in high-quality medical data science…
Helena Henno11/06/2020
